Social Impact Conversations Brand & Growth Resources Thinking Guide Climate access (CAST) CSR calculator About Founder Common questions Work with us

Thinking · Evidence

Climate is changing skin disease in 42.6% of countries: in India, nobody owns this door.

Abhijith Magal · 2 October 2026 · 8 min read

TL;DR

Climate change and skin disease now have a global survey connecting them. The SkinObservatory study, a collaboration between the International League of Dermatological Societies and L'Oréal Dermatological Beauty presented on 30 September at the EADV Congress in Vienna, collected responses from dermatology representatives in 136 countries across all four World Bank income groups. 42.6 per cent reported climate-linked changes in the prevalence or severity of skin disease, and the gradient runs the way climate injustice usually runs: 55.6 per cent of low-income countries, 52.5 per cent of lower-middle-income countries, 43.8 per cent of upper-middle, 28.3 per cent of high-income. The countries that contributed least report the most.

Among the 58 countries that detailed the effects, 81 per cent reported increases in heat rashes and 75.9 per cent in inflammatory skin disease. The study's authors describe two mechanisms: climate creating conditions for new or worsened skin disease directly, and climate making existing chronic skin conditions harder to manage, the continuity failure this site exists to name.

Who reports climate-linked skin disease change

SkinObservatory study, presented at EADV Congress 2026, Vienna, 30 September 2026. Share of surveyed countries in each World Bank income group reporting climate-related changes in skin disease prevalence or severity.
Income groupReporting change
Low income55.6%
Lower-middle income (includes India)52.5%
Upper-middle income43.8%
High income28.3%

Chart reads from the table above. The burden gradient runs inversely to income, with India's bracket second highest.

The door nobody in India walks through

Map India onto those rows and the picture assembles itself. A lower-middle-income country, so the 52.5 per cent bracket. Among the world's largest outdoor workforces: construction, agriculture, sanitation, delivery, street vending, all of it done through summers that now run longer and hotter, and through heat seasons that already strain the health system. Heat rash, fungal infection in the sweat-and-humidity months, inflammatory flare-ups, occupational dermatitis against hot surfaces and chemicals: the dermatology of outdoor work in a warming country is a daily clinical reality that appears in no heat action plan I have read, no BRSR disclosure, and almost no occupational health protocol beyond factory-gate first aid.

One survey finding doubles as a warning about measurement. In Africa, 42.9 per cent of respondents were unsure whether climate was affecting skin disease, which the study reads as a surveillance and dermatology-access gap rather than an absence of effect. India should assume it shares the gap. Skin disease is the most visible pathology there is and still goes uncounted, because the people who have it treat it as a cost of the job and the system that could record it never meets them.

Why skin is the cheap pilot

Skin conditions are diagnosable at the point of contact, by trained non-specialists with photographic referral; the treatments are mostly inexpensive; and improvement is visible to the patient and the funder alike. For a first climate-health intervention in an outdoor workforce, no other condition offers a shorter path from screening to countable outcome.

Who should fund the first one

Dermatology and consumer-health companies in India hold Section 135 budgets, scientific credibility in exactly this territory, and no established climate-health programme category to spend against. A worksite heat-and-skin pilot writes itself: screening days at construction and sanitation worksites in one hot district, a treatment-and-referral protocol, prevention built into the employer's heat measures alongside the duty-of-care obligations, and a log of days from symptom to care as the outcome. It is cheap, visible and honest, and it opens the climate-health door for a company category that has mostly watched pharma own the conversation. The partner-selection rules in implementing-partner screening apply unchanged.

One limit, stated plainly. This is a survey of dermatology-society representatives, one respondent set per country, co-funded by an industry partner with products in the category, and presented as a congress abstract rather than a peer-reviewed paper. It is a signal, and a strong one given the income gradient, not proof of national prevalence anywhere. An Indian pilot should treat its own baseline screening data as the first real measurement, which is part of the argument for running one.

Common questions

What did the SkinObservatory study find?

Of 136 countries surveyed, 42.6 per cent reported climate-linked changes in the prevalence or severity of skin disease, rising to 52.5 per cent in lower-middle-income and 55.6 per cent in low-income countries, against 28.3 per cent in high-income ones. Among the 58 countries detailing effects, 81 per cent reported more heat rashes and 75.9 per cent more inflammatory skin disease.

How does climate change affect skin disease?

Through two routes the study names: directly, as rising heat, humidity, extreme weather and ecosystem change create conditions for new or worsened skin conditions, heat rash and infections among them; and indirectly, by making chronic skin conditions harder to manage when heat, displacement and disrupted access break treatment routines.

Why is skin disease relevant to climate-health work in India?

India sits in the income bracket where 52.5 per cent of countries report climate-linked change, holds one of the world's largest outdoor workforces, and runs no systematic surveillance of occupational skin disease. The conditions are visible, treatable and uncounted, which makes them measurable low-hanging fruit.

What would a heat-and-skin pilot look like?

Screening days at outdoor worksites in one hot district, point-of-contact diagnosis with photographic referral for complex cases, inexpensive treatment and prevention integrated into the employer's heat measures, and days from symptom to care logged as the outcome. The design suits dermatology and consumer-health CSR budgets.

Where to start

The free climate-access exposure assessment gives a directional read on where climate is already reaching your access, workforce and supply chain, benchmarked against FY2024-25 BRSR disclosures from 59 listed Indian companies. Under three minutes, no sign-up.

Test your exposure →

The position, for citation

Abhijith Magal, founder of Syntropy Earth

Abhijith Magal

Founder, Syntropy Earth. Nine years across two global pharmaceutical multinationals in patient access and commercial roles, with health-equity work alongside the WHO-Foundation and UNICEF. He works on climate-access: where climate disruption breaks the link between patients and care.

Sources

  1. Khalfalla T, et al., "The global impact of climate change on dermatological disease: international results from 136 countries participating in the SkinObservatory study", EADV Congress 2026, Vienna, presented 30 September 2026.
  2. HCPLive, "Climate Change Tied to Skin Disease Worsening in 42% of Countries", October 2026. hcplive.com
  3. Medical Xpress, "Research reveals major impact of climate change on skin health worldwide", 30 September 2026, with income-group breakdowns. medicalxpress.com
  4. Dermatology Republic, "Climate change hitting skin health", October 2026, including the African surveillance-uncertainty finding and the direct and indirect mechanisms. dermatologyrepublic.com.au

This page reads published survey data. It is not clinical guidance; skin conditions need assessment and treatment by a qualified doctor.

Last updated: 3 October 2026

Free tool · runs in your browser

Now check the money side of the same year.

On 31 March, unspent CSR money goes one of two ways: into the company's own Unspent CSR Account, or out to a Schedule VII fund. The test is commencement, and board approval alone does not pass it. The calculator runs that test on your project list.

Nothing you type is stored or sent.